Factors influencing age at short stature
Conditions . | Age at short stature* . | |||
---|---|---|---|---|
Before 5 y old . | After 5 y old . | |||
H.R. . | P value . | H.R. . | P value . | |
Birth cohort | ||||
<1978 | 0.387 | .037 | n.s. | n.s. |
1978-1995 | ref. | ref. | ||
>1995 | n.s. | n.s. | 0.396 | .032 |
Age at start of chelation therapy, y | 0.796 | .031 | n.s. | n.s. |
Conditions . | Age at short stature* . | |||
---|---|---|---|---|
Before 5 y old . | After 5 y old . | |||
H.R. . | P value . | H.R. . | P value . | |
Birth cohort | ||||
<1978 | 0.387 | .037 | n.s. | n.s. |
1978-1995 | ref. | ref. | ||
>1995 | n.s. | n.s. | 0.396 | .032 |
Age at start of chelation therapy, y | 0.796 | .031 | n.s. | n.s. |
A stepwise Cox proportional hazards model was fitted for age at h-SDS less than −2. The model included sex as a stratifying variable and the following variables at first step: birth cohorts, age at start of transfusions, age at start of chelation therapy, intensive and/or early chelation with desferrioxamine, use of oral chelators, chronic hepatitis C, primary amenorrhea, hypogonadism, hypoparathyroidism, hypothyroidism, and diabetes.
H.R., hazard ratio; n.s., not significant; ref., reference category.
Short stature was defined as h-SDS less than −2.